GSK3B and diabetes mellitus: The link between the high activity of GSK3β and diabetes in human skeletal muscle is well established (Henriksen and Dokken, 2006), as is the therapeutic potential of GSK3β inhibitors (Dokken and Henriksen, 2006; Maqbool and Hoda, 2017).